PURPOSE: To examine whether serum insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) concentrations, determined early after the onset of stroke, are predictive of clinical outcome in elderly patients. METHODS: The sample comprised 85 patients (mean [SD] age, 83 7.4 years; range, 67 to 99 years; 34% male) who were admitted with acute stroke to a geriatric ward between January 1998 and June 2000, and 88 control patients who were similar in age and sex. Clinical and laboratory assessments, computed tomographic scan of the head, carotid ultrasonography, and electrocardiography were employed to define the clinical and etiologic stroke subtype. Fasting blood samples were collected within 24 hours of admission for IGF-I and IGFBP-3 measurement. Univariate and multiple logistic regression analyses, with adjustment for other related clinical covariates, were used to assess the relation of IGF-I and IGFBP-3 to poor outcome, defined as severe disability (Barthel index _60/100) or death, at 1 month (or at discharge), 3 months, and 6 months. RESULTS: Mean ( SD) IGF-1 levels were lower in patients with stroke than in controls (6945 ng/mL vs. 10267 ng/mL, P adjusted for age _ 0.001). The mean IGF-1/IGFBP-3 molar ratio was also lower in stroke patients (0.120.07 vs. 0.19 0.09, P adjusted for age <0.0001). However, there was no relation of hormone levels to either the clinical subtype of stroke or the extent of neurologic impairment. IGF-1 levels were inversely related to poor outcome (mainly death) at 3 and 6 months, independent of other clinical covariates that were highly predictive of outcome, such as age and stroke scale score on admission (hazard ratio for death at 6 months for each 20-ng/mL increase = 0.7; 95% confidence interval: 0.5 to 0.9). An independent association of the molar ratio with death at 3 and 6 months was also found. CONCLUSION: Low levels of circulating IGF-1 may predict the clinical outcome of stroke in elderly patients.
Insulin-like growth factor-1 as a predictor of ischemic stroke outcome in the elderly / Denti, L; Annoni, V; Cattadori, E; Salvagnini, Ma; Visioli, S; Merli, Mf; Corradi, F; Ceresini, Graziano; Valenti, G; Hoffman, Ar; Ceda, Gian Paolo. - In: THE AMERICAN JOURNAL OF MEDICINE. - ISSN 0002-9343. - 117:(2004), pp. 312-317. [10.1016/j.amjmed.2004.02.049]
Insulin-like growth factor-1 as a predictor of ischemic stroke outcome in the elderly
CERESINI, Graziano;VALENTI G;CEDA, Gian Paolo
2004-01-01
Abstract
PURPOSE: To examine whether serum insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) concentrations, determined early after the onset of stroke, are predictive of clinical outcome in elderly patients. METHODS: The sample comprised 85 patients (mean [SD] age, 83 7.4 years; range, 67 to 99 years; 34% male) who were admitted with acute stroke to a geriatric ward between January 1998 and June 2000, and 88 control patients who were similar in age and sex. Clinical and laboratory assessments, computed tomographic scan of the head, carotid ultrasonography, and electrocardiography were employed to define the clinical and etiologic stroke subtype. Fasting blood samples were collected within 24 hours of admission for IGF-I and IGFBP-3 measurement. Univariate and multiple logistic regression analyses, with adjustment for other related clinical covariates, were used to assess the relation of IGF-I and IGFBP-3 to poor outcome, defined as severe disability (Barthel index _60/100) or death, at 1 month (or at discharge), 3 months, and 6 months. RESULTS: Mean ( SD) IGF-1 levels were lower in patients with stroke than in controls (6945 ng/mL vs. 10267 ng/mL, P adjusted for age _ 0.001). The mean IGF-1/IGFBP-3 molar ratio was also lower in stroke patients (0.120.07 vs. 0.19 0.09, P adjusted for age <0.0001). However, there was no relation of hormone levels to either the clinical subtype of stroke or the extent of neurologic impairment. IGF-1 levels were inversely related to poor outcome (mainly death) at 3 and 6 months, independent of other clinical covariates that were highly predictive of outcome, such as age and stroke scale score on admission (hazard ratio for death at 6 months for each 20-ng/mL increase = 0.7; 95% confidence interval: 0.5 to 0.9). An independent association of the molar ratio with death at 3 and 6 months was also found. CONCLUSION: Low levels of circulating IGF-1 may predict the clinical outcome of stroke in elderly patients.File | Dimensione | Formato | |
---|---|---|---|
CEDA GP IGF-1 as a predictor of ischemic stroke outcome n 1.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
80.41 kB
Formato
Adobe PDF
|
80.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.